Hamburg, Hamburg, Germany The venture was found in Europe in Germany. The main department of described VC is located in the Hamburg.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Mulligan BioCapital, startups are often financed by Techno Venture Management, Sanders Morris Harris, Deutsche Venture Capital. The meaningful sponsors for the fund in investment in the same round are Techno Venture Management, Deutsche Venture Capital, BioMedPartners. In the next rounds fund is usually obtained by TVM Capital, NRW.BANK, Wellington Partners.
The higher amount of exits for fund were in 2014. The fund is constantly included in less than 2 deals per year. Opposing the other organizations, this Mulligan BioCapital works on 21 percentage points more the average amount of lead investments. The important activity for fund was in 2004. The common things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline 4SC, Cardion, 4-Antibody AG Among the most popular fund investment industries, there are Biopharma, Genetics. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
DIREVO Industrial Biotechnology | $16M | 18 Oct 2007 | Cologne, North Rhine-Westphalia, Germany | ||
Spinal Cord Therapeutics GmbH | $15M | 19 Sep 2005 | Germany, North Rhine-Westphalia, Germany | ||
4-Antibody AG | $3M | 17 Mar 2004 | Basel, Basel-City, Switzerland | ||
| $10M | 21 May 2003 | Germany, Bavaria, Germany | |||
DIREVO Industrial Biotechnology | $10M | 18 Dec 2000 | Cologne, North Rhine-Westphalia, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
DIREVO Industrial Biotechnology | $16M | 18 Oct 2007 | Cologne, North Rhine-Westphalia, Germany | ||
Spinal Cord Therapeutics GmbH | $15M | 19 Sep 2005 | Germany, North Rhine-Westphalia, Germany | ||
4-Antibody AG | $3M | 17 Mar 2004 | Basel, Basel-City, Switzerland | ||
| $10M | 21 May 2003 | Germany, Bavaria, Germany | |||
DIREVO Industrial Biotechnology | $10M | 18 Dec 2000 | Cologne, North Rhine-Westphalia, Germany |
